Jim Cramer on Thermo Fisher: “It Does Seem Like it’s Bottoming”

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 21 stocks on Jim Cramer’s radar. Expressing that they believe that the stock has significant potential for growth, a caller inquired about TMO. In response, Cramer said:

“This stock is unbelievable. It was a, it’s a great company. Marc Casper does a terrific job, but we own Danaher for the Charitable Trust, and it’s as bad as Thermo Fisher. I am urging you to not buy it till we see a pickup in Chinese orders. I know that seems strange, but this stock has crushed a lot of people. It does seem like it’s bottoming, but I am not going to push it because it’s related to China, and anything related to China is bearish.”

Jim Cramer on Thermo Fisher: "It Does Seem Like it’s Bottoming"

An engineer at a workbench surrounded by automotive parts, tools, and microchips.

Thermo Fisher (NYSE:TMO) provides a vast portfolio of products and services for scientific research, diagnostics, and biopharma, including instruments, reagents, laboratory supplies, and clinical research support. Parnassus Investments stated the following regarding Thermo Fisher Scientific Inc. (NYSE:TMO) in its Q4 2024 investor letter:

“Thermo Fisher Scientific Inc. (NYSE:TMO), a manufacturer of lab equipment and analytical tools, reported in-line quarterly numbers. However, expectations for a demand recovery in 2025 continue to moderate, particularly given uncertainty regarding the new administration.”

While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.